Next, to evaluate the synergistic anti-cancer effect of TNF family cytokines in lung cancer cells, we treated with 10 ng/ml TNF-α, 10 ng/ml TRAIL and 10 ng/ml FasL in HCC-95 and NCI-H460 cells. The gene discussed is TNF; the disease is hepatocellular carcinoma.